e-learning
resources
Virtual 2021
05.09.2021
Non-invasive respiratory support in COVID-19
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Risk factors for mortality in HFNO-treated Covid-19 positive patients – a pilot study
M. Labor (Värnamo, Sweden), L. Tokhi (Värnamo, Sweden), J. Paluero (Värnamo, Sweden), M. Roglic (Värnamo, Sweden)
Source:
Virtual Congress 2021 – Non-invasive respiratory support in COVID-19
Session:
Non-invasive respiratory support in COVID-19
Session type:
E-poster
Number:
1086
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Labor (Värnamo, Sweden), L. Tokhi (Värnamo, Sweden), J. Paluero (Värnamo, Sweden), M. Roglic (Värnamo, Sweden). Risk factors for mortality in HFNO-treated Covid-19 positive patients – a pilot study. 1086
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Risk factors of adverse outcome after acute hospitalization in Idiopathic Pulmonary Fibrosis (IPF)
Related content which might interest you:
Risk factors for all-cause mortality in patients with COPD: results from the ETHOS trial
Source: Virtual Congress 2021 – Inhaled treatments for COPD: clinical trials and real-world studies
Year: 2021
Mortality and prognostic factors in a cohort of COPD patients (EXACO study)
Source: Annual Congress 2010 - Comorbidity in obstructive airway disease
Year: 2010
Risk factors for post-COVID-19 condition in previously hospitalised children using the ISARIC Global follow-up protocol: a prospective cohort study
Source: Eur Respir J, 59 (2) 2101341; 10.1183/13993003.01341-2021
Year: 2022
Risk factors of re-hospitalisation for a COPD exacerbation: a prospective study
Source: Eur Respir J 2002; 20: Suppl. 38, 402s
Year: 2002
Risk of cardiovascular disease among patients with sarcoidosis: a population-based retrospective cohort study, 1976–2013
Source: Eur Respir J , 49 (2) 1601290; DOI: 10.1183/13993003.01290-2016
Year: 2017
Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study
Source: Eur Respir J, 55 (5) 2000524; 10.1183/13993003.00524-2020
Year: 2020
Risk factors for long-term hospitalization in patients with COVID 19
Source: Virtual Congress 2021 – COVID - 19 epidemiology
Year: 2021
Prevalence and risk factors for COPD in farmers: a cross-sectional controlled study
Source: Eur Respir J 2016; 47: 95-103
Year: 2016
Multinational, database cohort study to study mortality and risk factors of mortality in patients with asthma
Source: International Congress 2016 – Asthma and allergy in infancy: from risk factors to mortality
Year: 2016
Risk factors for diagnostic delay in a prospective IPF-cohort
Source: International Congress 2019 – The world of idiopathic pulmonary fibrosis
Year: 2019
Risk factors for childhood asthma: Which can be avoided? A case-control study
Source: Annual Congress 2010 - Allergy and risk factors in paediatrics
Year: 2010
Predicting factors for sarcoidosis outcome: retrospective cohort study
Source: International Congress 2019 – Sarcoidosis: a multifaceted disease that is difficult to manage
Year: 2019
Risk factors associated with MDR-TB deaths in Romania - 6 years retrospective study
Source: International Congress 2018 – Drug-resistant tuberculosis
Year: 2018
Survival estimates in European cystic fibrosis patients and the impact of socioeconomic factors: a retrospective registry cohort study
Source: Eur Respir J, 58 (3) 2002288; 10.1183/13993003.02288-2020
Year: 2021
The predictors of COVID-19 mortality in a nationwide cohort of Turkish patients
Source: Virtual Congress 2021 – COVID - 19 around the globe
Year: 2021
Risk factors for respiratory failure in patients with COVID-19 pneumonitis: A retrospective study
Source: Virtual Congress 2021 – COVID-19 and acute respiratory failure
Year: 2021
Safety and risk factors for the morbidity and mortality of pneumonectomies: a retrospective 10-year study in a single institution
Source: Virtual Congress 2020 – Thoracic surgery: malignancies
Year: 2020
Case-control study on risk factors to COPD – does the sampling of the cases and controls affect the results?
Source: Annual Congress 2008 - Epidemiology of respiratory symptoms and COPD
Year: 2008
Occupational risk factors for sarcoidosis in a multicenter case-control study
Source: Virtual Congress 2020 – Occupational lung diseases
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept